Long lagging in acceptance from providers, patients, and payers, telehealth has undergone a renaissance in use due tothe COVID-19 pandemic, enabling millions of peopleto receive care remotely for the first time. Patient advocates who had lobbied for the reimbursement of remote care for years saw a drastic reversal of policies, with public and private payers suspending their rules which had previously limited reimbursement for telehealth. Now that the pandemic appears to be ebbing in parts of the country, providers are wondering whether the regulatory and policy changes enacted during 2020 will remain. In this episode of CANCER BUZZ, we talk about what may change and what's likely to remain the same regarding reimbursement for telehealth this year and beyond.

Guest: Mei Wa Kwong, JD, Executive Director, Center for Connected Health Policy

Related Content:

• What Telehealth May Look Like in 2021
• ACCC Telehealth Resources
• Adoption and Expansion of Telehealth Solutions
• CANCER BUZZ Podcast: Telehealth After COVID-19
• On-Demand Webinar: Telehealth Reimbursement Update
• CMS: Sweeping Regulatory Changes to Help U.S. Healthcare System Address COVID-19 Patient Surge
• USNews: The Coronavirus Pandemic and the Transformation of Telehealth
• McKinsey & Company: Telehealth: A quarter-trillion-dollar post-COVID-19 reality?

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.